Thank You for Making this Conference a Huge Success!
Every patient is unique. Every cancer journey is unique. As a three-time cancer ‘sur-thrivor,’ Robert Weker, Principal, Weker Advisors LLC, and his family have faced the many challenges of this disease.
During #ISPEAM22, Robert provided his insights on his journey(s) - including participation in a clinical trial, finding the best medical team, and work and financial implications.
2021-2022 ISPE Board Chair Jörg Zimmermann, Vice President, Vetter Development Service, External Affairs, Vetter Pharma, spoke to ISPE’s mission and vision at #ISPEAM22
Keynote Julie Kim, President, U.S. Business Unit and U.S. Country Head, Takeda, shared with attendees how both she, and Takeda, approach collaboration and partnership in a way that keeps the patient front and center.
Keynote Andres Angelani, Global Head of Digital Engineering at Cognizant, shared his experiences working with multiple companies and across diverse industries to develop not only a transformative vision to meet the new business expectations, but also to implement that vision in order to realize successful outcomes.
Keynote Joydeep Ganguly, Senior Vice President, Corporate Operations, Gilead Sciences, is closing out the event with his presentation “Reimaging Value through Operations – How the Pandemic Redefined Emerging Trends in our Sector.”